Cochlear

Cochlear Total Shareholder Payout

The Total Shareholder Payout of Cochlear (COH.AX) as of Nov 15, 2026 is 307.90 M AUD. In the previous year, Total Shareholder Payout was 330.80 M AUD — a change of -6.92% (lower).

Total Shareholder Payout

307.90 MAUD

YoY

-6.92%

Last updated:

Total Shareholder Payout of Cochlear is 2026 307.90 M AUD. Total Shareholder Payout of Cochlear was 2025 330.80 M AUD. It decreases by -6.92% lower compared to the previous year.

The Cochlear Total Shareholder Payout history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Shareholder Payout
Date
Total Shareholder Payout
Jan 1, 2019
580.00 M AUD
Jan 1, 2020
413.10 M AUD
Jan 1, 2021
474.60 M AUD
Jan 1, 2022
195.10 M AUD
Jan 1, 2023
227.00 M AUD
Jan 1, 2024
291.50 M AUD
Jan 1, 2025
330.80 M AUD
Jan 1, 2026
307.90 M AUD
The Cochlear Total Shareholder Payout history
YEARTotal Shareholder PayoutYoY
307.90 MAUD-6.92%
330.80 MAUD+13.48%
291.50 MAUD+28.41%
227.00 MAUD+16.35%
195.10 MAUD-58.89%
474.60 MAUD+14.89%
413.10 MAUD-28.78%
580.00 MAUD+259.13%
161.50 MAUD-50.69%
327.50 MAUD-26.22%
443.86 MAUD+258.41%
123.84 MAUD-14.54%
144.91 MAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

Total Shareholder Payout of Cochlear is 307.90 M AUD in 2026.

Total Shareholder Payout of Cochlear changed from 330.80 M AUD to 307.90 M AUD, representing a -6.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Shareholder Payout Cochlear since 2006 – with annual values, charts, and detailed analysis.

Total shareholder payout combines dividends paid and share buybacks, representing the total cash returned to shareholders during the period.

Total Shareholder Payout's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Shareholder Payout's Cochlear historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Cochlear

All Key Metrics — Cochlear